retatrutide type 2 diabetes trial results Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 The Effect of Retatrutide on

Theres no one-size-fits-all, but little things count

Muchas personas llegan a consulta porque sienten que hacen dieta, intentan cuidarse, pero el hambre, los antojos o la ansiedad por comer hacen que sea muy difcil mantener los resultados

protein-rich foods like eggs, meat, and tofu

Improving insulin sensitivity Enhancing metabolic efficiency and reducing fat accumulation

Tirzepatide is not recommended during pregnancy or lactation, and women of reproductive potential should discontinue treatment if pregnancy is recognized

Referral to endocrinology, cardiology, or lipid specialists may be warranted for complex cases involving multiple cardiovascular risk factors, familial hypercholesterolemia, severe hypertriglyceridemia (500 mg/dL), or inadequate response to initial therapy